We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Updated: 11/30/2015
A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Updated: 11/30/2015
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Status: Enrolling
Updated: 11/30/2015
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Updated: 11/30/2015
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Updated: 11/30/2015
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Status: Enrolling
Updated: 11/30/2015
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Updated: 11/30/2015
Development of a Motivational Intervention to Improve Treatment Adherence in MS
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Updated: 11/30/2015
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Status: Enrolling
Updated: 11/30/2015
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Updated: 11/30/2015
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Updated: 11/30/2015
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Status: Enrolling
Updated: 11/30/2015
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Updated: 11/30/2015
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Advanced MRI Applications for Mild Traumatic Brain Injury
Updated: 11/30/2015
Advanced MRI Applications for Mild Traumatic Brain Injury
Status: Enrolling
Updated: 11/30/2015
Advanced MRI Applications for Mild Traumatic Brain Injury
Updated: 11/30/2015
Advanced MRI Applications for Mild Traumatic Brain Injury
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF
Updated: 11/30/2015
Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF
Status: Enrolling
Updated: 11/30/2015
Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF
Updated: 11/30/2015
Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Updated: 11/30/2015
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Updated: 11/30/2015
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Updated: 11/30/2015
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Updated: 11/30/2015
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Updated: 11/30/2015
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Updated: 11/30/2015
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Updated: 11/30/2015
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Updated: 11/30/2015
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Updated: 11/30/2015
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Updated: 11/30/2015
18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
TBI MR Study 3 Houston Methodist
Updated: 11/30/2015
Advanced MRI Applications for Mild Traumatic Brain Injury - Study 3
Status: Enrolling
Updated: 11/30/2015
TBI MR Study 3 Houston Methodist
Updated: 11/30/2015
Advanced MRI Applications for Mild Traumatic Brain Injury - Study 3
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes
Updated: 11/30/2015
Oxidative Stress and Cardiovascular Denervation in Diabetes: An Interventional Trial
Status: Enrolling
Updated: 11/30/2015
An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes
Updated: 11/30/2015
Oxidative Stress and Cardiovascular Denervation in Diabetes: An Interventional Trial
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
Updated: 11/30/2015
Improving Affect and Behavior in Assisted Living Residents
Status: Enrolling
Updated: 11/30/2015
Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
Updated: 11/30/2015
Improving Affect and Behavior in Assisted Living Residents
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
Updated: 11/30/2015
Improving Affect and Behavior in Assisted Living Residents
Status: Enrolling
Updated: 11/30/2015
Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
Updated: 11/30/2015
Improving Affect and Behavior in Assisted Living Residents
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Facilitating Caregiver Adaptation to Patient Institutionalization
Updated: 11/30/2015
Intervention to Facilitate Family Caregiver Adaptation to Nursing Home Transition
Status: Enrolling
Updated: 11/30/2015
Facilitating Caregiver Adaptation to Patient Institutionalization
Updated: 11/30/2015
Intervention to Facilitate Family Caregiver Adaptation to Nursing Home Transition
Status: Enrolling
Updated: 11/30/2015
Click here to add this to my saved trials
Psychological Effects of Tai Chi Training
Updated: 12/1/2015
Psychological Effects of Tai Chi Training
Status: Enrolling
Updated: 12/1/2015
Psychological Effects of Tai Chi Training
Updated: 12/1/2015
Psychological Effects of Tai Chi Training
Status: Enrolling
Updated: 12/1/2015
Click here to add this to my saved trials
A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness
Updated: 12/1/2015
A Double-Blind, Repeat-Dose, Parallel Group Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness.
Status: Enrolling
Updated: 12/1/2015
A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness
Updated: 12/1/2015
A Double-Blind, Repeat-Dose, Parallel Group Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness.
Status: Enrolling
Updated: 12/1/2015
Click here to add this to my saved trials
ARC in Hemorrhagic Stroke
Updated: 12/1/2015
Augmented Renal Clearance in Hemorrhagic Stroke Patients Admitted to the Neurosciences Intensive Care Unit
Status: Enrolling
Updated: 12/1/2015
ARC in Hemorrhagic Stroke
Updated: 12/1/2015
Augmented Renal Clearance in Hemorrhagic Stroke Patients Admitted to the Neurosciences Intensive Care Unit
Status: Enrolling
Updated: 12/1/2015
Click here to add this to my saved trials
Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MS
Updated: 12/1/2015
Project GET FIT With MS: Guidelines for Exercise Training and Fitness Outcomes in MS
Status: Enrolling
Updated: 12/1/2015
Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MS
Updated: 12/1/2015
Project GET FIT With MS: Guidelines for Exercise Training and Fitness Outcomes in MS
Status: Enrolling
Updated: 12/1/2015
Click here to add this to my saved trials
Intra-arterial Magnesium Administration for Acute Stroke
Updated: 12/2/2015
Intra-arterial Magnesium Therapy: A Novel Platorm for Neuroprotectant Delivery in Acute Stroke
Status: Enrolling
Updated: 12/2/2015
Intra-arterial Magnesium Administration for Acute Stroke
Updated: 12/2/2015
Intra-arterial Magnesium Therapy: A Novel Platorm for Neuroprotectant Delivery in Acute Stroke
Status: Enrolling
Updated: 12/2/2015
Click here to add this to my saved trials
Intra-arterial Magnesium Administration for Acute Stroke
Updated: 12/2/2015
Intra-arterial Magnesium Therapy: A Novel Platorm for Neuroprotectant Delivery in Acute Stroke
Status: Enrolling
Updated: 12/2/2015
Intra-arterial Magnesium Administration for Acute Stroke
Updated: 12/2/2015
Intra-arterial Magnesium Therapy: A Novel Platorm for Neuroprotectant Delivery in Acute Stroke
Status: Enrolling
Updated: 12/2/2015
Click here to add this to my saved trials
A Study of Pregnenolone in the Treatment of Individuals With Autism
Updated: 12/2/2015
An Open-Label Pilot Study of Pregnenolone in the Treatment of Individuals With Autism
Status: Enrolling
Updated: 12/2/2015
A Study of Pregnenolone in the Treatment of Individuals With Autism
Updated: 12/2/2015
An Open-Label Pilot Study of Pregnenolone in the Treatment of Individuals With Autism
Status: Enrolling
Updated: 12/2/2015
Click here to add this to my saved trials
An Open-Label Study of N-Acetyl Cysteine in Children With Autism
Updated: 12/2/2015
An Open-Label Study of N-Acetyl Cysteine in Autism
Status: Enrolling
Updated: 12/2/2015
An Open-Label Study of N-Acetyl Cysteine in Children With Autism
Updated: 12/2/2015
An Open-Label Study of N-Acetyl Cysteine in Autism
Status: Enrolling
Updated: 12/2/2015
Click here to add this to my saved trials
Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
Updated: 12/2/2015
Multiphase Study to Determine if Platelet Function Analysis Results Correlate With Ischemic Events and Bleeding Complications
Status: Enrolling
Updated: 12/2/2015
Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
Updated: 12/2/2015
Multiphase Study to Determine if Platelet Function Analysis Results Correlate With Ischemic Events and Bleeding Complications
Status: Enrolling
Updated: 12/2/2015
Click here to add this to my saved trials
Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
Updated: 12/3/2015
Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
Status: Enrolling
Updated: 12/3/2015
Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
Updated: 12/3/2015
Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
Status: Enrolling
Updated: 12/3/2015
Click here to add this to my saved trials
In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy
Updated: 12/3/2015
In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 12/3/2015
In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy
Updated: 12/3/2015
In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 12/3/2015
Click here to add this to my saved trials
Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia
Updated: 12/3/2015
Can Enhancing Left Lateralization Using Transcranial Direct Current Stimulation Improve Recovery From Post-Stroke Aphasia?
Status: Enrolling
Updated: 12/3/2015
Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia
Updated: 12/3/2015
Can Enhancing Left Lateralization Using Transcranial Direct Current Stimulation Improve Recovery From Post-Stroke Aphasia?
Status: Enrolling
Updated: 12/3/2015
Click here to add this to my saved trials
Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia
Updated: 12/3/2015
Can Enhancing Left Lateralization Using Transcranial Direct Current Stimulation Improve Recovery From Post-Stroke Aphasia?
Status: Enrolling
Updated: 12/3/2015
Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia
Updated: 12/3/2015
Can Enhancing Left Lateralization Using Transcranial Direct Current Stimulation Improve Recovery From Post-Stroke Aphasia?
Status: Enrolling
Updated: 12/3/2015
Click here to add this to my saved trials
Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
Updated: 12/3/2015
Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change
Status: Enrolling
Updated: 12/3/2015
Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
Updated: 12/3/2015
Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change
Status: Enrolling
Updated: 12/3/2015
Click here to add this to my saved trials
Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
Updated: 12/3/2015
Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change
Status: Enrolling
Updated: 12/3/2015
Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
Updated: 12/3/2015
Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change
Status: Enrolling
Updated: 12/3/2015
Click here to add this to my saved trials
Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis
Updated: 12/4/2015
Phase II, Randomized, Placebo Controlled Trial of the Safety and Tolerability of Mycophenolate in Children With Juvenile Neuronal Ceroid Lipofuscinosis
Status: Enrolling
Updated: 12/4/2015
Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis
Updated: 12/4/2015
Phase II, Randomized, Placebo Controlled Trial of the Safety and Tolerability of Mycophenolate in Children With Juvenile Neuronal Ceroid Lipofuscinosis
Status: Enrolling
Updated: 12/4/2015
Click here to add this to my saved trials
Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI
Status: Enrolling
Updated: 12/4/2015
Updated: 12/4/2015
Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI
Status: Enrolling
Updated: 12/4/2015
Updated: 12/4/2015
Click here to add this to my saved trials
Repetitive Transcranial Magnetic Stimulation Use in Acute Stroke
Updated: 12/4/2015
Real vs Sham rTMS Combined With Conventional Therapy in Acute Stroke
Status: Enrolling
Updated: 12/4/2015
Repetitive Transcranial Magnetic Stimulation Use in Acute Stroke
Updated: 12/4/2015
Real vs Sham rTMS Combined With Conventional Therapy in Acute Stroke
Status: Enrolling
Updated: 12/4/2015
Click here to add this to my saved trials
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
Updated: 12/4/2015
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
Updated: 12/4/2015
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
Click here to add this to my saved trials
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
Updated: 12/4/2015
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
Updated: 12/4/2015
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
Click here to add this to my saved trials
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
Updated: 12/4/2015
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
Updated: 12/4/2015
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
Click here to add this to my saved trials
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
Status: Enrolling
Updated: 12/4/2015
Updated: 12/4/2015
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
Status: Enrolling
Updated: 12/4/2015
Updated: 12/4/2015
Click here to add this to my saved trials
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
Status: Enrolling
Updated: 12/4/2015
Updated: 12/4/2015
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
Status: Enrolling
Updated: 12/4/2015
Updated: 12/4/2015
Click here to add this to my saved trials
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
Updated: 12/7/2015
A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
Status: Enrolling
Updated: 12/7/2015
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
Updated: 12/7/2015
A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
Status: Enrolling
Updated: 12/7/2015
Click here to add this to my saved trials
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
Updated: 12/7/2015
A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
Status: Enrolling
Updated: 12/7/2015
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
Updated: 12/7/2015
A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
Status: Enrolling
Updated: 12/7/2015
Click here to add this to my saved trials
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
Updated: 12/7/2015
A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
Status: Enrolling
Updated: 12/7/2015
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
Updated: 12/7/2015
A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
Status: Enrolling
Updated: 12/7/2015
Click here to add this to my saved trials